AU2003298546A1 - Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene - Google Patents

Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene

Info

Publication number
AU2003298546A1
AU2003298546A1 AU2003298546A AU2003298546A AU2003298546A1 AU 2003298546 A1 AU2003298546 A1 AU 2003298546A1 AU 2003298546 A AU2003298546 A AU 2003298546A AU 2003298546 A AU2003298546 A AU 2003298546A AU 2003298546 A1 AU2003298546 A1 AU 2003298546A1
Authority
AU
Australia
Prior art keywords
analysis
methods
nucleic acids
methylation status
cpg dinucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003298546A
Other languages
English (en)
Other versions
AU2003298546A8 (en
Inventor
Susan Cottrell
Suzanne Mooney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/215,890 external-priority patent/US20040029121A1/en
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2003298546A8 publication Critical patent/AU2003298546A8/xx
Publication of AU2003298546A1 publication Critical patent/AU2003298546A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2003298546A 2002-08-08 2003-08-08 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene Abandoned AU2003298546A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/215,890 2002-08-08
US10/215,890 US20040029121A1 (en) 2002-08-08 2002-08-08 Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene
US10/281,076 2002-10-25
US10/281,076 US20040029128A1 (en) 2002-08-08 2002-10-25 Methods and nucleic acids for the analysis of CpG dinucleotide methylation status associated with the calcitonin gene
PCT/US2003/025044 WO2004035806A2 (en) 2002-08-08 2003-08-08 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene

Publications (2)

Publication Number Publication Date
AU2003298546A8 AU2003298546A8 (en) 2004-05-04
AU2003298546A1 true AU2003298546A1 (en) 2004-05-04

Family

ID=32109763

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003298546A Abandoned AU2003298546A1 (en) 2002-08-08 2003-08-08 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene

Country Status (5)

Country Link
US (1) US20040029128A1 (enExample)
EP (1) EP1576190A4 (enExample)
JP (1) JP2005536229A (enExample)
AU (1) AU2003298546A1 (enExample)
WO (1) WO2004035806A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110151438A9 (en) * 2001-11-19 2011-06-23 Affymetrix, Inc. Methods of Analysis of Methylation
US20050233340A1 (en) * 2004-04-20 2005-10-20 Barrett Michael T Methods and compositions for assessing CpG methylation
AU2005250432B2 (en) 2004-05-28 2011-09-15 Asuragen, Inc. Methods and compositions involving microRNA
CA2857881A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
WO2008073922A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro rnas
US20060292585A1 (en) * 2005-06-24 2006-12-28 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
WO2008036776A2 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
WO2008036765A2 (en) * 2006-09-19 2008-03-27 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
CN101622349A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为治疗性干预靶标的miR-21调节的基因和途径
WO2008073920A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Mir-21 regulated genes and pathways as targets for therapeutic intervention
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
JP2010529966A (ja) * 2007-06-08 2010-09-02 アシュラジェン インコーポレイテッド 治療的介入の標的としてｍｉＲ−３４によって調節される遺伝子および経路
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
WO2009070805A2 (en) * 2007-12-01 2009-06-04 Asuragen, Inc. Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A2 (en) * 2007-12-21 2009-07-09 Asuragen, Inc. Mir-10 regulated genes and pathways as targets for therapeutic intervention
US20090263803A1 (en) * 2008-02-08 2009-10-22 Sylvie Beaudenon Mirnas differentially expressed in lymph nodes from cancer patients
US20090233297A1 (en) * 2008-03-06 2009-09-17 Elizabeth Mambo Microrna markers for recurrence of colorectal cancer
WO2009154835A2 (en) * 2008-03-26 2009-12-23 Asuragen, Inc. Compositions and methods related to mir-16 and therapy of prostate cancer
EP2990487A1 (en) 2008-05-08 2016-03-02 Asuragen, INC. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
WO2010056737A2 (en) * 2008-11-11 2010-05-20 Mirna Therapeutics, Inc. Methods and compositions involving mirnas in cancer stem cells
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
JP2021112127A (ja) * 2018-04-26 2021-08-05 暁生 黒田 膵β細胞の傷害検査方法
KR102728009B1 (ko) * 2022-10-28 2024-11-08 주식회사 비츠로셀 고온 특성이 향상된 이온전도성 전구체 전해액 및 이를 포함하는 에너지 저장 장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251594B1 (en) * 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
WO2001068911A2 (en) * 2000-03-15 2001-09-20 Epigenomics Ag Diagnosis of diseases associated with the cell cycle
AU2001277521A1 (en) * 2000-06-30 2002-01-14 Epigenomics Ag Diagnosis of diseases associated with cell signalling
EP1340818A1 (en) * 2002-02-27 2003-09-03 Epigenomics AG Method and nucleic acids for the analysis of a colon cell proliferative disorder
EP1540014A2 (en) * 2002-08-27 2005-06-15 Epigenomics AG Method and nucleic acids for the analysis of breast cell proliferative disorders

Also Published As

Publication number Publication date
US20040029128A1 (en) 2004-02-12
WO2004035806A2 (en) 2004-04-29
AU2003298546A8 (en) 2004-05-04
EP1576190A4 (en) 2006-10-18
EP1576190A2 (en) 2005-09-21
WO2004035806A3 (en) 2005-07-28
JP2005536229A (ja) 2005-12-02

Similar Documents

Publication Publication Date Title
AU2003298546A1 (en) Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
AU2002318336A1 (en) Methods and products for analyzing nucleic acids based on methylation status
AU2003299541A1 (en) Microfluidic nucleic acid analysis
AU2003259709A1 (en) Nucleic acid detection methods using universal priming
AU2003206095A1 (en) Methods and means for amplifying nucleic acid
AU2002325538A1 (en) Nucleic acid amplification methods
AU2003286535A1 (en) Methods of manipulating nucleic acids
AU2002347981A1 (en) Universal nucleotides for nucleic acid analysis
EP1436385A4 (en) DNA POLYMERASES AND MUTANTS CORRESPONDING
AU2003259682A1 (en) Diacylglycerol acyltransferase nucleic acid sequences and associated products
AU2003220249A1 (en) Improved nucleic acid amplification
AU2003230070A1 (en) Isolating nucleic acid
AU2003274915A1 (en) Recombinant double-stranded rna phages and uses thereof
AU2003273778A1 (en) Oligonucleotide analogues for detecting and analyzing nucleic acids
AU2002346517A1 (en) Thermus oshimai nucleic acid polymerases
AU5452300A (en) Target amplification of nucleic acid with mutant rna polymerase
AU2003205817A1 (en) Methods of nucleic acid amplification
AU2003285583A1 (en) Oligonucleotide guided analysis of gene expression
AU2003296087A1 (en) Nucleotide derivatives and dna microarray
AU2003233219A1 (en) Ssh based methods for identifying and isolating unique nucleic acid sequences
AU2003281281A1 (en) Methods and nucleic acids for the analysis of methylation patterns within the dd3 gene
AU2003219396A1 (en) Isolating nucleic acid
AU2003275946A1 (en) Gene expression in biological conditions
AU2002223637A1 (en) Nucleotide sequences which code for the mtra and mtrb gene
AU2002321858A1 (en) Method of determining blood-relationship by typing str alleles on the x chromosome and dna typing kit using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase